Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03071887 · ClinicalTrials.gov registry record · NA
Resilience Intervention for Older, HIV-Infected Women
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03071887: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03071887 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03071887, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The goal of this study is to refine and pilot the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and living with chronic disease. The investigators will adapt the 3RP resiliency intervention to the needs of this population and conduct preliminary testing of the group intervention via an open pilot study.
Interventions
- BEHAVIORAL Relaxation Response Resiliency Program (3RP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2018-08-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03071887
The ClinicalTrials.gov registry entry for NCT03071887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation Response Resiliency Program (3RP) is the first listed.
NCT03071887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03071887 about?
NCT03071887 is a clinical study titled "Resilience Intervention for Older, HIV-Infected Women". The goal of this study is to refine and pilot the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and living with chronic disease. The investigators will adapt the 3RP resiliency inter...
What is the current status of trial NCT03071887?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-11-27. Estimated completion is 2018-08-27.
What interventions are being tested in trial NCT03071887?
The interventions under investigation include: Relaxation Response Resiliency Program (3RP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03071887?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.